CAS: 1374853-91-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Pembrolizumab REF: 7W-GP2000CAS: 1374853-91-4 | (HPLC) ≥ 95.0% | To inquire | Fri 03 May 24 |
 | Pembrolizumab REF: TM-T9908CAS: 1374853-91-4 | 99.70% | 503.00 €~1,078.00 € | Thu 09 May 24 |
 | Pembrolizumab - in storage buffer (ca 25 mg/ml) REF: 3D-BP164049CAS: 1374853-91-4 | Min. 95 Area-% | 291.00 €~3,519.00 € | Mon 13 May 24 |
Pembrolizumab
CAS:1374853-91-4
Formula:
C6534H1000N1716O2036S46
Purity:
(HPLC) ≥ 95.0%
Color and Shape:
Colourless to light brown liquid
Molecular weight:
146286
Ref: 7W-GP2000
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 3 May 2024
Pembrolizumab
CAS:1374853-91-4
Pembrolizumab is a humanized monoclonal antibody inhibiting the PD-1 receptor and the first in the …
Purity:
99.70%
Color and Shape:
Solid
Molecular weight:
149 kDa
Ref: TM-T9908
| 5mg | 503.00 € | |
| 10mg | 664.00 € | |
| 25mg | 1,078.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Pembrolizumab - in storage buffer (ca 25 mg/ml)
CAS:1374853-91-4
Monoclonal antibody binds to PD-1 and blocks the interaction with PDL-1;cancer immunotherapy
Formula:
C6534H1000N1716O2036S46
Purity:
Min. 95 Area-%
Color and Shape:
Powder
Molecular weight:
137481.46146
Ref: 3D-BP164049
| 1mg | 291.00 € | |
| 5mg | 850.00 € | |
| 10mg | 1,072.00 € | |
| 25mg | 2,220.00 € | |
| 50mg | 3,519.00 € |
Estimated delivery in United States, on Monday 13 May 2024
